Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study

Author： Shimizu M.   Ogawa K.   Sasaki H.   Uehara Y.   Otsuka Y.   Okumura H.   Kusaka M.   Hasuda T.   Yamada T.   Mochizuki S.  

Publisher： Elsevier

ISSN： 0011-393X

Source： Current Therapeutic Research, Vol.64, Iss.9, 2003-11, pp. : 707-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis: An Open-Label Study

By Varma Rajat   Cafardi Jennifer A.   Cantrell Wendy   Elmets Craig  

American Journal of Clinical Dermatology, Vol. 9, Iss. 2, 2008-01 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference

By Stroberg P.   Murphy A.   Costigan T.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2724-2737

Elsevier

Access to resources Recommend Favorite

Peginterferon- -2a (40kD) and Ribavirin in Patients with Chronic Hepatitis C: A Phase II Open-Label Study

By Sulkowski M.  

BioDrugs, Vol. 16, Iss. 2, 2002-02 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study

By Eke F.U.   Anochie I.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 616-625

Elsevier

Access to resources Recommend Favorite

Tolerability and effects on quality of life of twice-daily extended-release carbamazepine in adults with seizure disorders: An open-label, 12- to 36-month continuation study

By Edward Hogan R.   Garnett W.R.   Thadani V.M.   Carbatrol Study Group  

Clinical Therapeutics, Vol. 25, Iss. 10, 2003-10 ,pp. : 2586-2596

Elsevier

Access to resources Recommend Favorite